Dr Shripad Banavali |Free Cancer treatment for needy kids |Tata Memorial Hospital |Beyond Boundaries
  • 3 years ago
Dr Shripad D. Banavali, Prof. and Head, Dept. of Medical & Pediatric Oncology, Tata Memorial Hospital, Mumbai, talks to ETHealthworld about the growing burden of cancer and changes that need to be made in order to make cancer treatment affordable and accessible to all. Dr Shripad D Banavali, the senior paediatric oncologist, said Tata Memorial treats 2500 cases of paediatric cancer every year. Nearly half of these cases are of blood cancer and the rest of cancerous tumours. “A lot of these children, while undergoing chemo, need admission. But at our Parel facility, we just do not have space. At ACTREC we will be able to admit more patients, making it possible for us to care for them better The dedicated ward for children will have counsellors and social workers attached to it,” he said.

#DrShripadBanavali #TataMemorialHospital #BeyondBoundaries #LokmatNews #CancerTreatment #ChildrenCancerTreatment

Dr Shripad Banaval | Free cancer treatment for needy kids |Tata Memorial Hospital IBeyond Boundaries

He did his MD in Internal Medicine in 1986 and underwent 3 years (1987-90) of Adult Oncology training at Tata Memorial Hospital, Mumbai under the able guidance of Dr S. H. Advani. During this period he wrote a research project on Chronic Myeloid Leukemia for which he got a Fellowship to work with Dr Harvey Priesler in Cincinnati, USA. He spent nearly 3 years there, doing research on various aspects of leukaemia and especially the CD 34 + hematogenic progenitor cells. In 1992, he moved to Memphis, Tennessee, the USA to work at St. Jude Children’s Research Hospital which is considered the “Mecca” of Pediatric Oncology. Here he did his Board Certification in Pediatrics and Fellowship in Pediatric Hematology-Oncology. After spending 8 years in the USA, he came back and joined Tata Memorial Hospital. At present, he is an Additional Professor and Consultant Medical Oncologist in charge of the Pediatric Leukemia / Lymphoma and Retinoblastoma section. He has a keen interest in leukaemia cell biology, immunology, cell kinetics and Experimental Oncology. He has more than 200 scientific publications in various peer-reviewed journals to his credit.



Subscribe to Our Channel
https://www.youtube.com/user/LokmatNews?sub_confirmation=1


Click Here For Latest News & Updates►http://www.lokmat.com

To Stay Updated Download the Lokmat App►
Android Google Play: http://bit.ly/LokmatApp

Like Us On Facebook ► https://www.facebook.com/lokmat
Follow Us on Twitter ►https://twitter.com/MiLOKMAT
Instagram ►https://www.instagram.com/milokmat
Recommended